<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Systemic <z:mp ids='MP_0001845'>inflammation</z:mp> impairs outcome in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients and experimental animals via mechanisms which are poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>Circulating <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> can activate cerebrovascular endothelium or glial cells in the brain and impact on ischaemic brain injury </plain></SENT>
<SENT sid="2" pm="."><plain>One of the most serious early clinical complications of <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> is <z:hpo ids='HP_0002181'>brain oedema</z:hpo>, which compromises survival in the first 24-48 h </plain></SENT>
<SENT sid="3" pm="."><plain>It is not understood whether systemic inflammatory challenges impair outcome after <z:hpo ids='HP_0001297'>stroke</z:hpo> by increasing brain injury only or whether they have direct effects on <z:hpo ids='HP_0002181'>brain oedema</z:hpo>, cerebrovascular <z:mp ids='MP_0001845'>inflammation</z:mp> and blood-brain barrier damage </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We used two different systemic inflammatory stimuli, <z:hpo ids='HP_0011009'>acute</z:hpo> endotoxin treatment and <z:mp ids='MP_0002531'>anaphylaxis</z:mp> to study mechanisms of brain injury after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) </plain></SENT>
<SENT sid="5" pm="."><plain>Ischaemic brain injury, blood-brain barrier damage and <z:hpo ids='HP_0000969'>oedema</z:hpo> were analysed by histological techniques </plain></SENT>
<SENT sid="6" pm="."><plain>Systemic cytokine responses and inflammatory changes in the brain were analysed by cytometric bead array, immunofluorescence, in situ hibridization and quantitative real-time PCR </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Systemic inflammatory challenges profoundly impaired survival in the first 24 h after experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> in mice, independently of an increase in <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="8" pm="."><plain>Systemic <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS) dose-dependently increased mortality (50-100%) minutes to hours after <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> anaphylactic challenge in ovalbumin-sensitised mice affected <z:hpo ids='HP_0001297'>stroke</z:hpo> more seriously when induced via intraperitoneal administration compared to intravenous </plain></SENT>
<SENT sid="10" pm="."><plain>Both LPS and <z:mp ids='MP_0002531'>anaphylaxis</z:mp> induced inflammatory changes in the blood and in the brain prior to experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Plasma cytokine levels were significantly higher after LPS, while increased IL-10 levels were seen after <z:mp ids='MP_0002531'>anaphylaxis</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>After MCAo, both LPS and <z:mp ids='MP_0002531'>anaphylaxis</z:mp> increased microglial interleukin-1α (IL-1α) expression and blood-brain barrier breakdown </plain></SENT>
<SENT sid="13" pm="."><plain>LPS caused marked granulocyte recruitment throughout the ipsilateral hemisphere </plain></SENT>
<SENT sid="14" pm="."><plain>To investigate whether reduction of ischaemic damage can improve outcome in systemic <z:mp ids='MP_0001845'>inflammation</z:mp>, controlled <z:hpo ids='HP_0002045'>hypothermia</z:hpo> was performed </plain></SENT>
<SENT sid="15" pm="."><plain><z:hpo ids='HP_0002045'>Hypothermia</z:hpo> reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size in <z:hpo ids='HP_0000001'>all</z:hpo> treatment groups and moderately improved survival, but failed to reduce excess <z:hpo ids='HP_0000969'>oedema</z:hpo> formation after <z:mp ids='MP_0002531'>anaphylaxis</z:mp> and LPS-induced neuroinflammation </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: Our results suggest that systemic inflammatory conditions induce cerebrovascular <z:mp ids='MP_0001845'>inflammation</z:mp> via diverse mechanisms </plain></SENT>
<SENT sid="17" pm="."><plain>Increased <z:mp ids='MP_0001847'>brain inflammation</z:mp>, blood-brain barrier injury and <z:hpo ids='HP_0002181'>brain oedema</z:hpo> formation can be major contributors to impaired outcome in mice after experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> with systemic inflammatory stimuli, independently of <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
</text></document>